留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

白色念珠菌TOR信号转导通路研究现状

梁华军,  阎澜,  曹永兵,  姜远英,  颜天华

downloadPDF
文章导航 > 药学实践与服务  > 2014 >  32(4): 246-249,287
梁华军, 阎澜, 曹永兵, 姜远英, 颜天华. 白色念珠菌TOR信号转导通路研究现状[J]. 药学实践与服务, 2014, 32(4): 246-249,287. doi: 10.3969/j.issn.1006-0111.2014.04.002
引用本文: 梁华军, 阎澜, 曹永兵, 姜远英, 颜天华. 白色念珠菌TOR信号转导通路研究现状[J]. 药学实践与服务, 2014, 32(4): 246-249,287. doi: 10.3969/j.issn.1006-0111.2014.04.002
shu
LIANG Huajun, YAN Lan, CAO Yongbing, JIANG Yuanying, YAN Tianhua. Advances in TOR pathway in Candida albicans[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(4): 246-249,287. doi: 10.3969/j.issn.1006-0111.2014.04.002
Citation: LIANG Huajun, YAN Lan, CAO Yongbing, JIANG Yuanying, YAN Tianhua. Advances in TOR pathway in Candida albicans[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(4): 246-249,287. doi: 10.3969/j.issn.1006-0111.2014.04.002
shu

白色念珠菌TOR信号转导通路研究现状

doi: 10.3969/j.issn.1006-0111.2014.04.002
  • 1.

    中国药科大学药学院, 江苏 南京 210009

  • 2.

    第二军医大学药学院新药研究中心, 上海 200433

基金项目: 国家973项目(2013CB531602);国家自然科学基金资助项目(31000079);上海市基础研究重点项目(14JC1417500).

Advances in TOR pathway in Candida albicans

  • 1.

    School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China

  • 2.

    Center for New Drug Research, School of Pharmacy, Second Military Medical University, Shanghai 200433, China

  • 摘要: 雷帕霉素靶(target of rapamycin,TOR)蛋白是真核细胞生长的关键调控因子,是一类进化上保守的丝氨酸/苏氨酸(Ser/Thr)蛋白激酶,属于磷脂酰肌醇相关激酶(phosphatidylinositol kinase-related kinases, PIKKs)家族。TOR信号通路通过参与调节翻译的起始和延伸,核糖体生成,蛋白质生物合成,氨基酸转运,以及多种代谢酶的转运而使细胞对外界环境刺激产生应答。在此对人类条件性致病菌白色念珠菌TOR信号通路的研究现状作一综述。
    Abstract: The target of rapamycin (TOR), a Ser/Thr protein kinase of PIKKs (phosphatidylinositol kinase-related kinases), is the central factor of a highly conserved signaling pathway in eukaryotes, and regulates cell growth in response to nutrients, hormones, and stresses.It controls temporal growth by activating anabolic processes such as translation, ribosome biogenesis, protein synthesis, transportation of amino acid and metabolic enzymes.The advances in TOR pathway in the most pervasive human fungal pathogen Candida albicans.
  • [1] Sehgal SN, Baker H, Vézina C. Rapamycin(AY-22,989), a new antifungal antibiotic.II. Fer-mentation, isolation and characterization[J]. J Antibiot, 1975, 28(19): 721-732.
    [2] 马 林, 万元胜, 陈东生. 他克莫司的临床应用[J]. 药物流行病学杂志, 2008, 17(1): 8-10.
    [3] Harding MW, Galat A, Uehling DE, et al. A receptor for the immuno-suppressant FK506 is a cistrans peptidyl-prolyl isomerase[J]. Nature, 1989, 341 (6244):758-760.
    [4] Heitman J, Movva NR, Hall MN. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast[J]. Scinece, 1991, 253(5022): 905-909.
    [5] Snydman DR. Shifting patterns in the epidemiology of nosocomial Candida infections[J]. Chest, 2003, 123(5 Supp1): 5.
    [6] 周建党, 黄 辉, 陈 颖, 等. 四年间酵母样真菌感染的病原菌分布与耐药特征分析[J]. 中国微生态学杂志. 2007, 19 (2): 202-203.
    [7] 路晓钦, 黎莉华, 周 丽, 等. 白假丝酵母菌感染分布及耐药性分析[J]. 中国感染控制杂志,2007, 6 (6): 419-421.
    [8] 吴文娟,胡绿荫,孙志华, 等. 获得性免疫缺陷综合征患者白假丝酵母分离株基因型及耐药性分析[J]. 检验医学,2007, 22(6): 684-687.
    [9] Dames SA, Mulet JM, Rathgeb-Szabo K, et al. The solution structure of the FATC domain of the protein kinase target of rapamycin suggests a role for redox-dependent structural and cel-lular stability[J]. J Biol Chem, 2005, 280(21): 20558-20564.
    [10] Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism[J]. Cell, 2006, 124(3): 471-484.
    [11] Rosenbach A, Dignard D, Pierce JV, et al. Adaptations of Candida albicans for growth in the mammalian Intestinal tract[J]. Eukaryot Cell, 2010, 9(7): 1075-1086.
    [12] Uhl MA, Biery M, Craiget N, et al. Haploin sufficiency-based large-scale forward genetic analysis of filamentous growth in the diploid human fungal pathogen C.albicans[J]. EMBO, 2003, 22 (11): 2668-2678.
    [13] Binda M, Péli-Gulli MP, Bonfils G, et al. The Vam6 GEF controls TORC1 by activating the EGO complex[J]. Mol Cell, 2009, 35(5): 563-573.
    [14] Zakikhany K, Naglik JR, Schmidt-Westhausen A, et al. In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination[J]. Cell Microbiol, 2007, 9(12): 2938-2954.
    [15] Tsao CC, Chen YT, Lan CY. A small G protein Rhb1 and a GTP ase-activating protein Tsc2 involved in nitrogen starvation-induced morphogenesis and cell wall integrity of Candida albicans[J]. Fungal Genet Biol, 2009, 46(2): 126-136.
    [16] Zacchi LF, Gomez-Raja J, Davis DA. Mds3 regulates morphogenesis in Candida albicans through the TOR pathway[J]. Mol Cell Biol, 2010, 30(14): 3695-3710.
    [17] Lee CM, Nantel A, Jiang LH, et al. The serine/threonine protein phosphatase SIT4 modulates yeast-to-hypha morphogenesis and virulence in Candida albicans[J]. Mol Microbol, 2004, 51(3): 691-709.
    [18] Liao WL, RamÓn AM, Fonzi WA. GLN3 encodes a global regulator of nitrogen metabolism and virulence of Candida albicans[J]. Fungal Genet Biol, 2008, 45(4): 514-526.
    [19] Huber A, Bodenmiller B, Uotila A, et al. Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis[J]. Genes Dev, 2009, 23: 1929-1943.
    [20] Liu W, Zhao JW, Li XC, et al. The protein kinase CaSch9p is required for the cell growth, filamentation and virulence in the human fungal pathogen Candida albica[J]. FEMS Yeast Res, 2010, 10(4): 462-470.
    [21] Li H, Tsang CK, Watkins M, et al. Nutrient regulates Tor1 nuclear localization and association with rDNA promoter[J]. Nature, 2006, 442: 1058-1061.
    [22] Strugill TW, Cohen A, Diefenbacher M, et al. TOR1 and TOR2 have distinct locations in live cells[J]. Eukaryot Cell, 2008, 7(10): 1819-1830.
    [23] Kim JE, Chen J. Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation[J]. PNAS, 2000, 97(26):14340-14345.
    [24] Kojic EM, Darouiche RO. Candida infections of medical devices[J]. Clin Microbiol, 2004, 17(2): 255-267.
    [25] Bastidas RJ, Heitman J, Cardenas ME. The protein kinase Tor1 regulates adhesin gene expression in Candida albicans[J]. PLoS Pathol, 2009, 5(2): e1000294.
    [26] Tsuchimori N, Sharkey LL, Fonzi WA, et al. Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells[J]. Infect Immun, 2000, 68(4): 1997-2002.
    [27] Nobile CJ, Mitchell AP. Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p[J]. Curr Biol, 2005, 15(12): 1150-1155.
    [28] Lempiäinen H, Uotila A, Urban J, et al. Sfp1 interaction with TORC1 and Mrs6 reveals feedback regulation on TOR signaling[J]. Mol Cell, 2009, 33(6): 704-716.
    [29] Rohde JR, Cardenas ME. Nutrient signaling through TOR kinases controls gene expression and cellular differentiation in fungi[J]. Curr Top Microbiol, 2004, 279: 53-72.
    [30] Rohde JR, Bastidas R, Puria R, et al. Nutritional control via Tor sinaling in Saccharomyces cerevisiae[J]. Curr Opin Microbiol, 2008, 11(2): 153-160.
    [31] Zurita-Martine SA, Cardenas ME. Tor and cyclic AMP-Protein kinase A:two parallel pathways regulating expression of genes required for cell growth[J]. Eukaryot Cell, 2005, 4(1): 63-71.
    [32] Pedruzzi I, Dubouloz F, Cameroni E, et al. TOR and PKA signaling pathways converge on the protein kinase Rim15 to control entry into G0 [J]. Mol Cell, 2003, 12(6): 1607-1613.
    [33] Soulard A, Cohenl A, Hall MN. TOR signaling in invertebrates[J]. Curr Opin Cell Biol, 2009, 21(6): 825-836.
  • [1] 徐飞, 陈瑾, 鲁育含, 李志勇.  肠道菌群参与糖尿病肾病的机制研究进展 . 药学实践与服务, 2024, 42(5): 181-184, 197. doi: 10.12206/j.issn.2097-2024.202312023
    [2] 尹小娟, 台力丽, 肖俊峰, 季波.  铜绿假单胞菌合并按蚊伊丽莎白菌肺部感染的病例分析 . 药学实践与服务, 2024, 42(5): 223-226. doi: 10.12206/j.issn.2097-2024.202310042
    [3] 宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅.  帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(7): 1-7. doi: 10.12206/j.issn.2097-2024.202303023
    [4] 唐淑慧, 凤美娟, 薛智霞, 鲁桂华.  帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029
    [5] 史生辉, 石飞, 雷琼, 王亚峰, 吴雪花.  青藏高原肺结核合并念珠菌感染患者的病原菌分布特点及耐药率分析 . 药学实践与服务, 2024, 42(6): 260-262, 272. doi: 10.12206/j.issn.2097-2024.202304014
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  2976
  • HTML全文浏览量:  262
  • PDF下载量:  455
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-01-23
  • 修回日期:  2013-05-20

白色念珠菌TOR信号转导通路研究现状

doi: 10.3969/j.issn.1006-0111.2014.04.002
  • 1. 中国药科大学药学院, 江苏 南京 210009
  • 2. 第二军医大学药学院新药研究中心, 上海 200433
    • 基金项目:  国家973项目(2013CB531602);国家自然科学基金资助项目(31000079);上海市基础研究重点项目(14JC1417500).
  • 收稿日期: 2013-01-23
  • 修回日期: 2013-05-20

摘要: 雷帕霉素靶(target of rapamycin,TOR)蛋白是真核细胞生长的关键调控因子,是一类进化上保守的丝氨酸/苏氨酸(Ser/Thr)蛋白激酶,属于磷脂酰肌醇相关激酶(phosphatidylinositol kinase-related kinases, PIKKs)家族。TOR信号通路通过参与调节翻译的起始和延伸,核糖体生成,蛋白质生物合成,氨基酸转运,以及多种代谢酶的转运而使细胞对外界环境刺激产生应答。在此对人类条件性致病菌白色念珠菌TOR信号通路的研究现状作一综述。

English Abstract

梁华军, 阎澜, 曹永兵, 姜远英, 颜天华. 白色念珠菌TOR信号转导通路研究现状[J]. 药学实践与服务, 2014, 32(4): 246-249,287. doi: 10.3969/j.issn.1006-0111.2014.04.002
引用本文: 梁华军, 阎澜, 曹永兵, 姜远英, 颜天华. 白色念珠菌TOR信号转导通路研究现状[J]. 药学实践与服务, 2014, 32(4): 246-249,287. doi: 10.3969/j.issn.1006-0111.2014.04.002
shu
LIANG Huajun, YAN Lan, CAO Yongbing, JIANG Yuanying, YAN Tianhua. Advances in TOR pathway in Candida albicans[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(4): 246-249,287. doi: 10.3969/j.issn.1006-0111.2014.04.002
Citation: LIANG Huajun, YAN Lan, CAO Yongbing, JIANG Yuanying, YAN Tianhua. Advances in TOR pathway in Candida albicans[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(4): 246-249,287. doi: 10.3969/j.issn.1006-0111.2014.04.002
shu

    全文HTML

参考文献 (33)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计